ASMI Code of Practice encourages best standards of behaviour

29 May 2014

Return to Media Release Index

29 May 2014 - The Australian Self Medication Industry (ASMI) Code of Practice demonstrates a commitment by the non-prescription medicines industry to aspire to the best standards of behaviour, said Steve Scarff, ASMI Director Regulatory and Scientific Affairs, at the 7th Annual Pharmaceutical Law Conference in Sydney.

"The ASMI Code of Practice sets the ethical standards for advertising and promotion of non-prescription medicines in Australia. This system of self-regulation complements the co-regulatory advertising controls and the legislative requirements of the Therapeutic Goods Regulations 1990 and Therapeutic Goods Act 1989," explained Mr Scarff. "It follows the National Medicines Policy which aims to improve health outcomes for all Australians."
Mr Scarff said that all ASMI members must comply with the Code which covers advertising to health care professionals and all advertising to consumers.

"The Code assists ASMI members to responsibly inform consumers about products; make accurate, balanced and objective claims and promote Quality Use of Medicines (QUM)," commented Mr Scarff. "It sets a high standard of conduct by ASMI members and is applied in spirit as well as the letter."

"Last year we made several changes to the Code to ensure consistency with other Codes of Practice in the therapeutic sectors and to create a level playing field between members and non-members. The changes make expectations clearer and provide more certainty," said Mr Scarff.

About the Speaker: Steven Scarff
Steven Scarff is the Regulatory and Scientific Affairs Director of ASMI. Steven is a solicitor and a scientist with a long history in regulatory affairs in the pharmaceutical industry.
Steven has over 20 years industry experience with more than ten years in regulatory affairs, working on over-the-counter (OTC) products with major ASMI member companies.

He has also worked as a consultant in regulatory affairs and, as a qualified solicitor, has participated in ASMI meetings to provide guidance in trade practices compliance.
Steven began his working career in the laboratory. He then moved on to regulatory roles of increasing seniority with Pfizer Consumer Healthcare and Johnson & Johnson Pacific before establishing himself as a solicitor and regulatory affairs consultant.

About ASMI: The Australian Self Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines. Its members make up 85 per cent of the $4bn self care market. Membership totals 60 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to promote better health through responsible self care. This means ensuring that safe and effective self care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self medication products as part of the broad national health strategy.

For more information or to arrange a media interview, please contact:
Marie Kelly-Davies
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: